跳至主要内容
临床试验/NL-OMON42309
NL-OMON42309已完成不适用

Monitoring therapy success of Chlamydia trachomatis infections using culture<br>A prospective observational cohort study.<br> - Chlamydia test-of-cure study

GGD Amsterdam0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Born to female sex
  • Age *18 years
  • Tested Ct NAAT-positive on urogenital swab
  • Eligible for azithromycin treatment (no allergies)
  • Willing to receive the routine treatment for Chlamydia trachomatis at the STI Outpatient Clinic
  • Accepting conditions of the study and signed informed consent

排除标准

  • Tested NAAT-positive on urine sample only
  • Not being able to give informed consent, based on Dutch or English patient information
  • Ct infection in the past 3 months
  • Antibiotic treatment for which Chlamydia trachomatis is sensitive (rifampicin, tetracyclines, macrolides, sulfonamides, quinolones, clindamycin, penicillins, cephalosporins) between day -28 and day 0.
  • Unlikely to comply with the study requirements

研究者

发起方
GGD Amsterdam

相似试验

Monitoring therapy success of Chlamydia trachomatis... | 临床试验